NCT07112950Not yet recruiting
Press Needle Acupuncture for Pain and Quality of Life in Lung Cancer Patients
The Effect of Press Needle Acupuncture on Pain Reduction and Quality of Life Improvement in Lung Cancer Patients
Source: ClinicalTrials.gov · Last updated 8 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of this clinical trial is to evaluate the effect of press needle acupuncture on pain management and quality of life improvement in patients with lung cancer. The main question this study aims to answer is: Does press needle acupuncture, when combined with standard therapy, provide better pain relief and quality of life improvement in lung cancer patients compared to standard therapy alone? Researchers will compare press needle acupuncture to sham acupuncture to determine whether press needle acupuncture is more effective in reducing pain and improving quality of life. Participants will: Receive either press needle acupuncture or sham press needle acupuncture for 7 days Visit the clinic once a week for examination and evaluation Record improvements in pain intensity in a pain diary and assess quality of life using a quality of life questionnaire
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- First submitted
- 1 Aug 2025
- Start date
- 11 Aug 2025
- Primary completion date
- 31 Oct 2025
- Lead sponsor
- Universitas Indonesia
- Diseases
- Lung cancer
- NCT number
- NCT07112950
What you commit to
- Study type: Interventional
- Planned participants: 32
- From 11 Aug 2025 to the primary completion date, 31 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Lung cancer patients with deteriorating general condition.
- Presence of wounds or infections at the press needle insertion site.
- History of allergy to stainless steel materials.
Lab values
- Patients with blood clotting disorders: platelet count \<50,000/μL, ANC \<1000/mm³, or patients undergoing anticoagulant therapy with INR \>2.142.
Who the study is looking for
- Patients with a confirmed diagnosis of lung cancer through histopathology or radiology.
- Lung cancer patients aged over 18 years.
- Stage III-IV lung cancer patients receiving therapy at Dr. Cipto Mangunkusumo National General Hospital (RSUPN) and Tangerang District General Hospital (RSUD Kabupaten Tangerang).
- Patients with a VAS score \>10 mm for baseline pain and \>40 mm during breakthrough pain.
- Willing to participate in the study until completion by signing the informed consent form.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitas Indonesia Coordinator of this site? Confirm its status | Jakarta Pusat | Indonesia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.